New long-term data on St. Jude Medical Inc.’s CardioMEMS HF System, taken from prospective findings coming out of the CHAMPION study, show that after 31 months of follow-up, CardioMEMS HF-managed patients had a 48% reduction in heart failure hospitalizations compared with patients managed with the standard of care, ie based on outward signs of worsening HF.
The results, published in online in The Lancet in early November, demonstrate the effectiveness of monitoring pulmonary artery pressure for...